QT
AGIO icon

Quantamental Technologies’s Agios Pharmaceuticals AGIO Stock Holding History

Quantamental Technologies’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,573
Closed -$271K – 440
2022
Q3 		$271K Buy
+9,573
New +$257K 0.11% 335
2019
Q1 		– Sell
-601
Closed -$28K – 1444
2018
Q4 		$28K Buy
+601
New +$37.1K 0.02% 935

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Quantamental Technologies's AGIO Position: Q4 2022 in Review

Quantamental Technologies sold out of Agios Pharmaceuticals (AGIO) in Q4 2022, closing a stake of 9,573 shares — an estimated $271K sold.

Quantamental Technologies first reported a position in AGIO in Q4 2018 and held it in 2 quarters. The position peaked at $271K in Q3 2022. 159 funds tracked by Wall St. Rank hold AGIO as of Q4 2022.

  • Quantamental Technologies reported no remaining Agios Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Quantamental Technologies sold 9,573 Agios Pharmaceuticals shares in Q4 2022, an estimated $271K.
  • Quantamental Technologies first reported a position in Agios Pharmaceuticals in Q4 2018 and held it in 2 quarters.
  • Quantamental Technologies's Agios Pharmaceuticals position peaked at $271K in Q3 2022.
  • 159 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2022.

Based on Quantamental Technologies's 13F filing for Q4 2022, filed 14 Feb 2023.